These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 36936971)
1. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma. Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z Front Immunol; 2023; 14():1086342. PubMed ID: 36936971 [TBL] [Abstract][Full Text] [Related]
2. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y Front Immunol; 2022; 13():892750. PubMed ID: 35812416 [TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
4. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma. Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y Front Oncol; 2023; 13():1144269. PubMed ID: 37056349 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples. Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347 [TBL] [Abstract][Full Text] [Related]
6. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma. Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689 [TBL] [Abstract][Full Text] [Related]
7. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Xu H; Xiong C; Chen Y; Zhang C; Bai D Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis. Wang J; Huang R; Huang Y; Chen Y; Chen F Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma. Yu ZL; Zhu ZM Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330 [TBL] [Abstract][Full Text] [Related]
10. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy. Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of correlation between high expression of nucleoporin 85 (NUP85) and immune cell infiltration in hepatocellular carcinoma]. Liu X; Ding Z; Wu H; Ma J; Lu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jun; 40(6):508-519. PubMed ID: 38952090 [TBL] [Abstract][Full Text] [Related]
12. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis]. Wang GN; Zhang YP; Wang MC; Han W; Zhang YC Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095 [No Abstract] [Full Text] [Related]
13. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Jiang W; Wu T; Shi X; Xu J Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781 [TBL] [Abstract][Full Text] [Related]
14. INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Li W; Hong G; Lai X Mediators Inflamm; 2023; 2023():7057236. PubMed ID: 37181806 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
16. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB Front Oncol; 2021; 11():665192. PubMed ID: 34123827 [TBL] [Abstract][Full Text] [Related]
17. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma. Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061 [TBL] [Abstract][Full Text] [Related]
18. Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses. Cao J; Zhang C; Jiang GQ; Jin SJ; Wang Q; Wang AQ; Bai DS Bioengineered; 2021 Dec; 12(1):296-309. PubMed ID: 33380242 [TBL] [Abstract][Full Text] [Related]
19. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma. Lin P; Wen DY; Li Q; He Y; Yang H; Chen G Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]